ad image

New Drug Application

1 / 1
Clearside Biomedical
NDA

Clearside Biomedical Provides New Drug Application Update for XIPEREᵀᴹ (triamcinolone acetonide suprachoroidal injectable suspension)

Clearside Biomedical

PR-M08-19-NI-077Aug 27, 2019
Janssen Pharmaceutical Companies
New Drug Application

Janssen Submits Supplemental New Drug Application to U.S. FDA for INVOKANA® (canagliflozin) for the Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes

Janssen Pharmaceutical Companies

PR-M04-19-NI-008Apr 02, 2019
More Positive Results for Novartis Eye Drug Brolucizumab
Macular Degeneration

More Positive Results for Novartis Eye Drug Brolucizumab

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M11-18-NI-002Nov 05, 2018
Janssen Pharmaceutical Companies
New Drug Application

Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer

Janssen Pharmaceutical Companies

PR-M09-18-NI-083Sep 26, 2018
Ortho Dermatologics
NDA

Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) Lotion

Ortho Dermatologics

PR-M09-18-NI-057Sep 19, 2018
Nektar Therapeutics
Drug Application

Nektar Therapeutics Announces New Drug Application for NKTR-181 Accepted for Review by FDA

Nektar Therapeutics

PR-M08-18-NI-011Aug 03, 2018
Bayer
Drug Application

FDA Accepts Larotrectinib New Drug Application and Grants Priority Review

Bayer

PR-M05-18-NI-115May 31, 2018
1 / 1